Legal Representation
Attorney
Chelsea E. Carbone
USPTO Deadlines
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 8, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 8, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 6, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 11, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 11, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 22, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 7, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 7, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 7, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 7, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 7, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 21, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 21, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 21, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 20, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 16, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for targeting and destroying bacteria; pharmaceutical preparations for the treatment of antibiotic-resistant bacterial infections and microbiome-related disorders; pharmaceutical preparations for use in the field of engineered bacteriophage; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases namely, transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases
Classification
International Classes
005